This report presents the long-term (over 15 years) results of four Japanese patients who underwent total joint replacement for thumb carpometacarpal (CMC) joint arthritis. Four patients (mean age 60.5 years) underwent prosthesis replacement for thumb CMC joint arthritis with AVANTA(TM) (Small Bone Innovations, Morrisville, PA, USA) implants between 2001 and 2004, with a mean follow-up of 20 years and seven months. One patient was classified as Eaton stage 2 and three patients were classified as Eaton stage 3 prior to surgery. Although radiographs at the last follow-up showed loosening of the trapezium-side implant in all cases, three of the patients were excellent and only one was good according to Eaton's clinical criteria, and none of them reported severe pain or significant problems. Despite radiographic evidence of implant loosening and subsidence, long-term results were positive with minimal clinical symptoms. The results suggest that thumb CMC joint arthroplasty can provide satisfactory long-term results. However, the use of thumb CMC joint prostheses is currently limited in Japan, and alternative surgical methods such as suspension arthroplasty are more common. We believe that the thumb CMC joint prosthesis is as effective as any other surgical method based on the good results we have seen.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11634552 | PMC |
http://dx.doi.org/10.7759/cureus.73480 | DOI Listing |
Cureus
November 2024
Orthopaedic Surgery, Toho University Ohashi Medical Center, Tokyo, JPN.
This report presents the long-term (over 15 years) results of four Japanese patients who underwent total joint replacement for thumb carpometacarpal (CMC) joint arthritis. Four patients (mean age 60.5 years) underwent prosthesis replacement for thumb CMC joint arthritis with AVANTA(TM) (Small Bone Innovations, Morrisville, PA, USA) implants between 2001 and 2004, with a mean follow-up of 20 years and seven months.
View Article and Find Full Text PDFJ Hand Microsurg
December 2024
Department of Orthopaedic Surgery, University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
Background: Thumb carpometacarpal (CMC) joint osteoarthritis is among the most common degenerative hand diseases. Thumb CMC arthroplasty, or trapeziectomy with or without tendon augmentation, is the most frequently performed surgical treatment and has a strong safety profile. Though adverse outcomes are infrequent, the ability to predict risk for complications has substantial clinical benefits.
View Article and Find Full Text PDFOsteoarthr Cartil Open
March 2025
Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.
Objective: Our primary objectives are to assess whether intraarticular corticosteroid injections are superior to saline injections with regards to thumb base pain after 4 weeks, and to compare the efficacy of steroid injections, saline injections, and an occupational therapy intervention on thumb base pain after 12 weeks in people with painful inflammatory osteoarthritis (OA) of the first carpometacarpal (CMC-1) joint.
Design: In this three-armed, double-blind, randomized multicenter trial, 354 participants with painful inflammatory CMC-1 OA from six Norwegian hospitals are recruited. Participants are randomized 1:1:1 to intraarticular steroid or saline injections in the CMC-1 joint or a multimodal occupational therapy intervention.
J Hand Surg Am
December 2024
Department of Orthopedic Surgery, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong-si, Republic of Korea. Electronic address:
Purpose: Arthrodesis and ligament reconstruction and tendon interposition (LRTI) are commonly performed procedures for treatment of thumb carpometacarpal (CMC) osteoarthritis. Although LRTI is the most common surgical treatment, CMC arthrodesis has been performed because of its reported advantages. This systematic review and meta-analysis compared the differences between CMC arthrodesis and LRTI to better inform surgeons and patients when they are making treatment decisions.
View Article and Find Full Text PDFJ Food Sci
December 2024
Joint Research Center for Food Nutrition and Health of IHM, College of Food and Nutrition, Anhui Agricultural University, Hefei, China.
Green tea seed oil (GTSO; Camellia sinensis) is rich in bioactive compounds and has great potential for preventing intestinal inflammation. Conversely, high-fat diets have been shown to promote or aggravate gastrointestinal inflammation, and the bioactive ingredients of GTSO face difficulty passing through the gastrointestinal tract while remaining intact. This study employed whey protein isolate (WPI) and sodium carboxymethyl cellulose (CMC-Na) to prepare a GTSO-loaded double-layer emulsion.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!